邓如芝,林娜,倪灵芝,于翠,杜蓓,胡建民,杨晓慧,于旭东,Frank Thron Alan Johnston,吕帆
:325027 温州医科大学附属眼视光医院(邓如芝、林娜、倪灵芝、于旭东、吕帆);110163 沈阳,沈阳何氏
医学院(于翠);300070 天津医科大学眼科医院(杜蓓);362000 泉州,福建医科大学附属第二医院(胡建民);100730
北京市眼科研究所,首都医科大学附属北京同仁医院眼科中心(杨晓慧);02115 Boston, New England College of
Optometry (Frank Thron);8002 Melbourne, East Melbourne Optometry & Low Vision Centre (Alan Johnston)
Translation and Revision of the Functional Low-Vision Observer RatedAssessment
Ruzhi Deng1, Na Lin1, Lingzhi Ni1, Cui Yu2, Bei Du3, Jianmin Hu4, Xiaohui Yang5, Xudong Yu1,#br# Frank Thron6, Alan Johnston7, Fan Lu1
1Eye Hospital, Wenzhou Medical University, Wenzhou 325027, China
2He University, Shenyang 110163, China
3Tianjin Medical University Eye Hospital, Tianjin 300070, China
4The Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, China
5Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730,
China
6New England College of Optometry, Boston 02115, US
7East Melbourne Optometry & Low Vision Centre, Melbourne 8002, Austria
Objective: To translate and revise the Functional Low-Vision Observer Rated Assessment (FLORA) into a Chinese version. Methods: The FLORA was translated into the appropriate Chinese version (FLORA-C1).It was then revised by low vision experts in China according to different cultures. The translated and revised version formed the FLORA-C2. Results: The experts were familiar with the low vision assessments, and the authority coefficient was 0.86. After the translation and revision, FLORA-C2 consisted of each patient's basic information, assessment instructions, and assessment. The assessment was divided into three sections:self-reports, evaluation, and a summary report. The self-reports section consisted of 12 open-ended questions. The evaluation section included four visual abilities: Visual orientation, visual mobility, daily life, and interactions with others. Conclusions: The main use of the FLORA-C2 will be for evaluating the visual function and quality of life of Chinese patients who have an implanted retinal prosthesis. It can also help to evaluate the effect of other treatments or systems.
邓如芝,林娜,倪灵芝,于翠,杜蓓,胡建民,杨晓慧,于旭东,Frank Thron Alan Johnston,吕帆 . 极低视力视觉功能观察评估量表汉化及修订[J]. 中华眼视光学与视觉科学杂志, 2018, 20(2): 92-.
Ruzhi Deng1, Na Lin1, Lingzhi Ni1, Cui Yu2, Bei Du3, Jianmin Hu4, Xiaohui Yang5, Xudong Yu1,. Translation and Revision of the Functional Low-Vision Observer RatedAssessment. Chinese Journal of Optometry Ophthalmology and Visual science, 2018, 20(2): 92-. DOI: 10.3760/cma.j.issn.1674-845X.2018.02.005.
Pascolini D, Mariotti SP. Global estimates of visual impairment:2010. Br J Ophthalmol, 2012, 96(5): 614-618. DOI: 10.1136/
[2]
Stelmack JA, Stelmack TR, Massof RW. Measuring low-vision rehabilitation outcomes with the NEI VFQ-25. Invest Ophthalmol Vis Sci, 2002, 43(9): 2859-2868.
bjophthalmol-2011-300539.
[3]
Stelmack JA, Szlyk JP, Stelmack TR, et al. Psychometric properties of the Veterans Affairs Low-Vision Visual Functioning Questionnaire. Invest Ophthalmol Vis Sci, 2004,
45
(11): 3919-3928. DOI: 10.1167/iovs.04-0208.
[4]
Seo JH, Yu HG, Lee BJ. Assessment of functional vision score and vision-specific quality of life in individuals with retinitis pigmentosa. Korean J Ophthalmol, 2009, 23(3): 164-168. DOI:10.3341/kjo.2009.23.3.164.
[5]
Sugawara T, Hagiwara A, Hiramatsu A, et al. Relationship between peripheral visual field loss and vision-related quality of life in patients with retinitis pigmentosa. Eye (Lond), 2010,24(4): 535-539. DOI: 10.1038/eye.2009.176.
[6]
Dagnelie G. Retinal implants: emergence of a multidisciplinary field. Curr Opin Neurol, 2012, 25(1): 67-75. DOI: 10.1097/WCO.0b013e32834f02c3.
[7]
Geruschat DR, Bittner AK, Dagnelie G. Orientation and mobility assessment in retinal prosthetic clinical trials.Optom Vis Sci, 2012, 89(9): 1308-1315. DOI: 10.1097/
[2]
Stelmack JA, Stelmack TR, Massof RW. Measuring low-vision rehabilitation outcomes with the NEI VFQ-25. Invest Ophthalmol Vis Sci, 2002, 43(9): 2859-2868.
OPX.0b013e3182686251.
[8]
Geruschat DR, Flax M, Tanna N, et al. FLORATM: Phase Ⅰ development of a functional vision assessment for prosthetic vision users. Clin Exp Optom, 2015, 98(4): 342-347. DOI:
[3]
Stelmack JA, Szlyk JP, Stelmack TR, et al. Psychometric properties of the Veterans Affairs Low-Vision Visual Functioning Questionnaire. Invest Ophthalmol Vis Sci, 2004,
45
(11): 3919-3928. DOI: 10.1167/iovs.04-0208.
[4]
Seo JH, Yu HG, Lee BJ. Assessment of functional vision score and vision-specific quality of life in individuals with retinitis pigmentosa. Korean J Ophthalmol, 2009, 23(3): 164-168. DOI:10.3341/kjo.2009.23.3.164.
[5]
Sugawara T, Hagiwara A, Hiramatsu A, et al. Relationship between peripheral visual field loss and vision-related quality of life in patients with retinitis pigmentosa. Eye (Lond), 2010,24(4): 535-539. DOI: 10.1038/eye.2009.176.
[6]
Dagnelie G. Retinal implants: emergence of a multidisciplinary field. Curr Opin Neurol, 2012, 25(1): 67-75. DOI: 10.1097/WCO.0b013e32834f02c3.
[7]
Geruschat DR, Bittner AK, Dagnelie G. Orientation and mobility assessment in retinal prosthetic clinical trials.Optom Vis Sci, 2012, 89(9): 1308-1315. DOI: 10.1097/
10
1111/cxo.12242.
OPX.0b013e3182686251.
[8]
Geruschat DR, Flax M, Tanna N, et al. FLORATM: Phase Ⅰ development of a functional vision assessment for prosthetic vision users. Clin Exp Optom, 2015, 98(4): 342-347. DOI:
10
1111/cxo.12242.
[9]
Geruschat DR, Richards TP, Arditi A, et al. An analysis of observer-rated functional vision in patients implanted with the Argus Ⅱ Retinal Prosthesis System at three years. Clin Exp
Geruschat DR, Richards TP, Arditi A, et al. An analysis of observer-rated functional vision in patients implanted with the Argus Ⅱ Retinal Prosthesis System at three years. Clin Exp